» Articles » PMID: 3893156

Control of Intestinal Absorption by the Renin-angiotensin System

Overview
Journal Am J Physiol
Specialty Physiology
Date 1985 Jul 1
PMID 3893156
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

In vivo angiotensin II (ANG II) exerts a dose-dependent dual action upon intestinal absorption. At low doses, ANG II stimulates sodium (Na) and water absorption from all intestinal areas. At high doses, ANG II inhibits absorption. The stimulation of jejunal absorption in response to ANG II is secondary to the release of norepinephrine (NE) from enteric sympathetic nerves. ANG II may act either within the brain or at the sympathetic nerve terminal to liberate NE. In contrast, the inhibition of absorption in response to ANG II is due to enteric prostaglandin production. At the present time it is unclear whether the changes in absorption in response to ANG II in vivo are due to changes in transport processes or secondary to alterations in enteric hemodynamics. ANG II also exerts a dose-dependent dual action on intestinal ion and water absorption in vitro. The mechanisms responsible for changes in absorption in vitro are unknown. However, since enteric sympathetic nerves are severed from their ganglia, it is unlikely that ANG II stimulates absorption in isolated preparations through release of NE. ANG II exerts a major control over intestinal absorption following volume depletion. The hormone controls colonic absorption through release of aldosterone and directly influences jejunal absorption via enteric sympathetic nerves. ANG II may control ileal absorption following volume depletion. All components of the renin-angiotensin system are present within the intestine. Furthermore, ANG II-like immunoreactivity is present within enteric nerves. The role of locally formed ANG II in the control of intestinal absorption has not been studied. Models illustrating the effect of ANG II on intestinal absorption are discussed.

Citing Articles

Long-term health outcomes associated with hydration status.

Dmitrieva N, Boehm M, Yancey P, Enhorning S Nat Rev Nephrol. 2024; 20(5):275-294.

PMID: 38409366 DOI: 10.1038/s41581-024-00817-1.


Dysregulation of intestinal epithelial electrolyte transport in canine chronic inflammatory enteropathy and the role of the renin-angiotensin-aldosterone-system.

Dengler F, Domenig O, Kather S, Burgener I, Steiner J, Heilmann R Front Vet Sci. 2023; 10:1217839.

PMID: 37720474 PMC: 10500592. DOI: 10.3389/fvets.2023.1217839.


Gut microbiota and renin-angiotensin system: a complex interplay at local and systemic levels.

Jaworska K, Koper M, Ufnal M Am J Physiol Gastrointest Liver Physiol. 2021; 321(4):G355-G366.

PMID: 34405730 PMC: 8486428. DOI: 10.1152/ajpgi.00099.2021.


Association of sprue-like enteropathy and angiotensin receptor-1 antagonists.

Wenzel R, Datz C Wien Klin Wochenschr. 2019; 131(19-20):493-501.

PMID: 31471672 DOI: 10.1007/s00508-019-01539-2.


Angiotensin II inhibits P-glycoprotein in intestinal epithelial cells.

Kumar A, Priyamvada S, Soni V, Anbazhagan A, Gujral T, Gill R Acta Physiol (Oxf). 2019; 228(1):e13332.

PMID: 31177627 PMC: 6899205. DOI: 10.1111/apha.13332.